1. Columbia University (11 from 2,489 patents)

2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (8 from 3,539 patents)

3. Johns Hopkins University (4 from 3,688 patents)

4. University of Utah Research Foundation (4 from 1,650 patents)

5. Baylor College of Medicine (4 from 601 patents)

6. University of Iowa Research Foundation (2 from 906 patents)

7. Other (1 from 832,880 patents)

8. Aventis Pharma S.a. (1 from 377 patents)

1. 12404277 - Substituted 4-phenylpiperidines, their preparation and use

2. 11649240 - Substituted 4-phenylpiperidines, their preparation and use

3. 10913746 - Substituted 4-phenylpiperidines, their preparation and use

4. 10407433 - Substituted 4-phenylpiperidines, their preparation and use

5. 10072016 - Substituted 4-phenylpiperidines, their preparation and use

6. 9777010 - Substituted 4-phenylpiperidines, their preparation and use

7. 9434727 - Substituted 4-phenylpiperidines, their preparation and use

8. 9333202 - Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease

9. 9063139 - Variants in complement regulatory genes predict age-related macular degeneration

10. 8980924 - Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease

11. 8129353 - Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter

12. 8012683 - Variants in complement regulatory genes predict age-related macular degeneration

13. 7192579 - Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter

14. 7189511 - Methods of screening and diagnostics using ATP-binding cassette transporter

15. 7141420 - Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter